Jazz Pharmaceuticals, an Ireland-based biopharmaceutical company, and other defendants were hit with an antitrust lawsuit Friday in California Northern District Court. The court action claims that the defendants engaged in a scheme to restrain competition for the narcolepsy treatment Xyrem and its generic bioequivalents in the United States. The complaint was brought by Schneider Wallace Cottrell Konecky; and Lowey Dannenberg P.C. on behalf of Molina Healthcare, a health care management business offering services through government programs. Counsel have not yet appeared for the defendants. The case is 3:21-cv-07935, Molina Healthcare Inc. v. Jazz Pharmaceuticals, Inc. et al.
The complaint follows a similar antitrust suit from Humana. Schneider Wallace Cottrell Konecky and Lowey Dannenberg filed a complaint Friday against Jazz Pharmaceuticals, Hikma Pharmaceuticals, Amneal Pharmaceuticals and other generic drug makers in California Northern District Court over alleged antitrust violations. Counsel have not yet appeared for the defendants. The case is 3:21-cv-07934, Humana Inc. v. Jazz Pharmaceuticals, Inc. et al.
